Arm’s CEO warns chip shortage hampers AI cancer research

The CEO of Arm has warned that the ongoing chip shortage is significantly hindering AI advancements within cancer research. This scarcity of essential hardware delays critical breakthroughs in drug discovery and the development of new treatments. According to the Arm boss, the lack of available chips acts as a bottleneck, slowing down the pace at which AI can be utilized to find cures for cancer and improve overall patient outcomes in the medical field.